Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sonsini Peter W.
Relationship:   10% Owner
City:   Menlo Park
State:   CA
   
Insider Summary:
  
   
Companies Owned :   39    
Direct Shares   66,219,175    

Indirect Shares

   287,129,918      
Direct Value   $484,917,870    

Indirect Value

   $554,586,967      
Total Shares   353,349,093      
Total Value   $1,039,504,837      


Mersana Therapeutics, Inc. $1,915 Surface Oncology, Inc. $3,095,378 Appian Corp $10,851 Reneo Pharmaceuticals, Inc. $8,757,454 Ionq Ord Shs $273,589,607 Enliven Therapeutics Ord Shs $0 Arcellx, Inc. $0 Senti Biosciences, Inc $1,612,447 Zerofox Holdings Ord Shs $197,850,217 Mersana Therapeutics, Inc. $1,915 Surface Oncology, Inc. $3,095,378 Appian Corp $10,851 Reneo Pharmaceuticals, Inc. $8,757,454 Ionq Ord Shs $273,589,607 Enliven Therapeutics Ord Shs $0 Arcellx, Inc. $0 Senti Biosciences, Inc $1,612,447 Zerofox Holdings Ord Shs $197,850,217
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    0    

     Stock price went up :
    2   
    0    
     Stock price went down :
    3   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   21.6%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Ardelyx Inc ARDX 10% Owner 0 2019-12-09 6,564,372    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2020-01-24 102,478,668    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2022-10-19 24    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2020-09-14 745 2020-09-14 596    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2020-12-04 6,451,056    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2020-05-20 2,892,877 2018-04-23 3,312,877    Premium*  
            Appian Corp APPN 10% Owner 2018-02-13 339 2018-02-13 676    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2022-05-25 0    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2022-04-11 948,948    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 0 2019-07-22 4,186,243    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 0 2022-11-30 0    Premium*  
            Nkarta, Inc. NKTX 10% Owner 2020-07-14 0 2020-07-14 2,902,115    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2020-07-28 2,437,689    Premium*  
            Metacrine, Inc. MTCR 10% Owner 2020-09-18 0 2021-12-22 2,563,257    Premium*  
            Eargo, Inc. EAR 10% Owner 2020-10-20 0 2021-05-24 821    Premium*  
            Desktop Metal Ord Shs Class A DM 10% Owner 0 2021-06-08 54    Premium*  
            Savara Inc SVRA 10% Owner 0 2021-03-15 24,137,931    Premium*  
            Marker Therapeutics Inc MRKR 10% Owner 2021-03-16 0 2021-03-16 10,714,285    Premium*  
            Reneo Pharmaceuticals, Inc. RPHM 10% Owner 2021-04-13 4,785,494 2021-04-13 0    Premium*  
            Bright Health Group Inc. BHG 10% Owner 0 2021-06-28 23,983,073    Premium*  
            Monte Rosa Therapeutics, Inc. GLUE 10% Owner 2021-06-28 0 2021-06-28 7,692,298    Premium*  
            Robinhood Markets, Inc. HOOD Director 2021-08-02 0 2022-05-02 270    Premium*  
            Ionq Ord Shs IONQ 10% Owner 2022-05-31 26,306,693 2022-11-16 70    Premium*  
            Enliven Therapeutics Ord Shs ELVN 10% Owner 2022-01-25 3,305,601 2021-12-27 0    Premium*  
            Casper Sleep Inc. CSPR 10% Owner 2022-01-25 0 2022-01-25 0    Premium*  
            Arcellx, Inc. ACLX 10% Owner 2022-02-08 6,432,762 2022-12-20 12    Premium*  
            Senti Biosciences, Inc SNTI 10% Owner 2022-06-08 4,426,151 0    Premium*  
            Zerofox Holdings Ord Shs ZFOX 10% Owner 2022-08-03 18,068,513 0    Premium*  
            Oyster Point Pharma, Inc. OYST 10% Owner 2023-01-03 0 2023-01-03 0    Premium*  
* Premium Members only  

Records found :    176         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EAR Eargo, Inc. 10% Owner   –       –       •   2020-10-20 4 A $0.00 $0 I/I 6,208,906 6,208,906 0 -
EAR Eargo, Inc. 10% Owner   –       –       •   2021-05-24 4 D $0.00 $0 I/I (2,030,000) 0 0 -
EAR Eargo, Inc. 10% Owner   –       –       •   2021-05-24 4 A $0.00 $0 I/I 30,821 821 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-27 4 S $2.42 $67,007 D/D (27,651) 3,695,192 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-28 4 S $2.34 $57,539 D/D (24,580) 3,670,612 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-29 4 S $2.30 $34,954 D/D (15,196) 3,655,416 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-07 4 S $2.08 $30,318 D/D (14,600) 3,492,424 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-10 4 S $2.00 $3,502 D/D (1,751) 3,490,673 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-11 4 S $2.04 $4,919 D/D (2,409) 3,488,264 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-12 4 S $2.02 $9,357 D/D (4,634) 3,483,630 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-13 4 S $1.93 $13,886 D/D (7,209) 3,476,421 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-14 4 S $1.91 $18,583 D/D (9,707) 3,466,714 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-18 4 S $1.89 $12,927 D/D (6,848) 3,459,866 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-19 4 S $1.82 $24,414 D/D (13,412) 3,446,454 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-20 4 S $1.81 $11,385 D/D (6,295) 3,440,159 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-21 4 S $1.67 $19,389 D/D (11,622) 3,428,537 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-24 4 S $1.55 $31,017 D/D (19,984) 3,408,553 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-01-25 4 S $1.47 $151,803 D/D (102,952) 3,305,601 0 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2019-02-14 4 B $0.47 $4,688,619 I/I 9,948,269 34,948,269 1.5 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2019-06-24 4 B $3.50 $9,999,997 I/I 2,857,142 7,225,676 1.5 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2020-07-24 4 B $2.25 $7,090,335 I/I 3,151,260 10,376,936 1.5 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2022-05-24 4 S $0.07 $387,943 I/I (5,931,843) 4,445,093 0 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2022-05-25 4 S $0.08 $362,720 I/I (4,445,093) 0 0 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 B $16.00 $4,000,000 I/I 250,000 2,437,689 1.5 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 I/I 2,187,689 2,187,689 0 -
  176  Records found
  1   2   3   4  5   6   7   8      
  Page 4 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us